US Border Protection warns pharma of risks with incorrect biologic importation
The incorrect transport of biological materials opens the US up to risk of infectious disease and biological threats, says Sean…
The incorrect transport of biological materials opens the US up to risk of infectious disease and biological threats, says Sean…
The United Arab Emirates (UAE)’s clinical research landscape, is quickly developing with a regulatory framework coming into place over the…
Social media has become an excellent tool for targeting specific patients for clinical trials, says Chris Adams, the CEO at…
Social media has become an excellent tool for targeting specific patients for clinical trials, says Chris Adams, the CEO at…
As artificial intelligence (AI) permeates clinical trial operations more than ever, workforces will have to adapt to the changing tides,…
A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said a researcher at…
A shift in the beta-blocker treatment paradigm has arrived with the changing myocardial infarction treatment landscape, said a researcher at…
Antibody drug conjugates (ADCs) have taken over the cancer clinical research and dealmaking landscape, with new partnerships and agreements being…
“Change begins now,” said the UK’s new prime minister, Sir Keir Starmer, in his 5 July victory speech. Ending the…
Whilst Prime Minister Rishi Sunak and Labour party leader Keir Starmer, centre attention on migration and tax policies, the UK…